アフェレシス市場規模、シェア、成長分析、製品別、施術別、技術別、用途別、エンドユーザー別、地域別-産業予測、2024～2031年

アフェレシスの世界市場規模は、2022年に28億米ドルと評価され、2023年の31億米ドルから2031年には72億米ドルに成長し、予測期間（2024～2031年）のCAGRは11.1％で成長する展望です。

アフェレシス市場は、疾病の有病率の増加と安全な血液成分に対する需要の高まりに後押しされ、大幅な成長が見込まれています。アフェレシス技術における革新的な進歩が手技の有効性を高め、有利な償還施策と資金調達の増加が市場力学をさらに強化します。アフェレシスは、血栓性血小板減少性紫斑病、自己免疫疾患、敗血症など、さまざまな疾患の一次治療または補助療法として応用されており、その汎用性と有効性が強調され、臨床での採用が広がっています。さらに、現在進行中の製品革新と規制当局の承認は、市場拡大を推進する上で極めて重要です。しかし、市場成長の勢いを維持するためには、熟練した専門家の不足、血液汚染の懸念、高い手技コストなどの課題に対処する必要があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主要市場の考察

• 重要成功要因
• 競合の程度
• 規制情勢
• 主要投資機会
• 市場の魅力指数
• 技術の進歩
• 市場エコシステム
• 特許分析
• バリューチェーン分析
• ケーススタディ分析
• マクロ経済指標

アフェレシス市場規模：製品別&CAGR（2024～2031年）

• 市場概要
• アフェレシス用消耗品
  • 遠心力アフェレシス装置
  • 膜分離装置
• アフェレシス用装置

アフェレシス市場規模：施術別&CAGR（2024～2031年）

• 市場概要
• 血漿交換
• 血小板成分採取
• 赤血球除去療法
• 白血球除去療法
• 光線療法
• LDLアフェレーシス
• その他

アフェレシス市場規模：技術別&CAGR（2024～2031年）

• 市場概要
• 遠心分離
  • 連続流遠心分離機
  • 間欠流遠心分離
• 膜分離

アフェレシス市場規模：用途別&CAGR（2024～2031年）

• 市場概要
• 腎臓疾患
• 神経学
• 血液学
• がん
• 自己免疫疾患
• 心血管疾患
• その他

アフェレシス市場規模：エンドユーザー別&CAGR（2024～2031年）

• 市場概要
• 血液採取センターと血液成分供給業者
• 病院と輸血センター
• その他

アフェレシス市場規模&CAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
• 製品ポートフォリオ分析
• セグメント別シェア分析
• 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Terumo BCT, Inc.（日本）
• Fresenius Medical Care（ドイツ）
• Haemonetics Corporation（米国）
• Baxter International（米国）
• Asahi Kasei Medical Co., Ltd.（日本）
• Kaneka Corporation（日本）
• Cerus Corporation（米国）
• B. Braun Melsungen AG（ドイツ）
• Macopharma SA（フランス）
• Kawasumi Laboratories（日本）
• Nikkiso Co., Ltd（日本）
• Medica SPA（イタリア）
• Miltenyi BIoTec（ドイツ）
• Otsuka Holdings（JIMRO）（日本）
• Cytosorbents Corporation（米国）
• Bioelettronica S.r.l.（イタリア）
• Guangzhou Daji Medical（中国）
• Beijing ZKSK Technology（中国）
• Infomed SA（スイス）
• Haier Biomedical（中国）

結論と推奨事項

Global Apheresis Market size was valued at USD 2.8 billion in 2022 and is poised to grow from USD 3.1 billion in 2023 to USD 7.2 billion by 2031, growing at a CAGR of 11.1% during the forecast period (2024-2031).

The apheresis market is poised for substantial growth, fueled by an increasing prevalence of diseases and the heightened demand for secure blood components. Innovative advancements in apheresis techniques are enhancing procedural efficacy, while favorable reimbursement policies and increased funding further bolster market dynamics. The application of apheresis as a primary or adjunct therapy for a range of conditions-such as thrombotic thrombocytopenic purpura, autoimmune disorders, and sepsis-highlights its versatility and effectiveness, driving wider clinical adoption. Furthermore, ongoing product innovations and regulatory approvals are pivotal in propelling market expansion. However, challenges including a shortage of skilled professionals, blood contamination concerns, and high procedural costs must be addressed to maintain the market's growth momentum.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Apheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Apheresis Market Segmental Analysis

Global Apheresis Market is segmented by product, procedure, technology, application, end user and region. Based on Product, the market is segmented into Apheresis Disposals and Apheresis Devices. Based on Procedure, the market is segmented into Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis, LDL-apheresis, and Others. Based on technology, the market is segmented into Centrifugation, and Membrane Separation. Based on application, the market is segmented into Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases, Cardiovascular Diseases and others. Based on end user, the market is segmented into Blood Collection Centers & Blood Component Providers, Hospitals & Transfusion Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Apheresis Market

The global apheresis market is significantly propelled by the growing prevalence of chronic diseases, including cancer, autoimmune disorders, and cardiovascular issues. As these conditions become more widespread, the demand for apheresis procedures increases, as they are vital in managing these health challenges by selectively extracting or collecting specific blood components. This process not only enhances patient outcomes but also supports the trend toward personalized medicine. By allowing for tailored treatments that target individual patient needs-either through the removal of harmful substances or the collection of specific blood components for further therapeutic or research purposes-apheresis aligns well with modern healthcare approaches focused on personalization and precision.

Restraints in the Global Apheresis Market

The global apheresis market faces several restraints that impede its growth. One of the foremost challenges is the high cost linked to apheresis devices and the therapeutic procedures involved. These costs, combined with the complexities of installation and maintenance of such equipment, create barriers to entry for many healthcare facilities. Furthermore, the substantial financial investment needed for both acquiring apheresis devices and executing therapeutic procedures can deter wider adoption. Additionally, a lack of awareness surrounding apheresis among potential blood donors contributes to lower participation rates in apheresis-based blood donation, further obstructing market expansion and limiting its overall potential.

Market Trends of the Global Apheresis Market

The Global Apheresis market is witnessing a significant trend toward the adoption of personalized medicine and targeted therapies, driven by rapid advancements in healthcare technologies. As clinicians increasingly emphasize individualized treatment approaches, the demand for apheresis procedures tailored to specific patient profiles is rising. This shift is enhancing therapeutic efficacy by allowing for more precise interventions based on patient-specific medical conditions and genetic characteristics. Additionally, the integration of innovative apheresis technologies is further supporting clinical efforts to improve patient outcomes. Consequently, the market is evolving, presenting lucrative opportunities for stakeholders who can adapt to these personalized healthcare paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Regulatory Landscape
• Top Investment Pockets
• Market Attractiveness Index
• Technology Advancement
• Market Ecosystem
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Macro-Economic Indicators

Global Apheresis Market Size by Product & CAGR (2024-2031)

• Market Overview
• Apheresis Disposals
  • Centrifugal Apheresis Devices
  • Membrane Separators
• Apheresis Devices

Global Apheresis Market Size by Procedure & CAGR (2024-2031)

• Market Overview
• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• LDL-apheresis
• Others

Global Apheresis Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Centrifugation
  • Continuous Flow Centrifugal
  • Intermittent Flow Centrifugation
• Membrane Separation

Global Apheresis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Renal Diseases
• Neurology
• Haematology
• Cancer
• Autoimmune Diseases
• Cardiovascular Diseases
• Others

Global Apheresis Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Blood Collection Centers & Blood Component Providers
• Hospitals & Transfusion Centers
• Others

Global Apheresis Market Size & CAGR (2024-2031)

• North America (Product, Procedure, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Procedure, Technology, Application, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Procedure, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Procedure, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (JIMRO) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytosorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioelettronica S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Daji Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haier Biomedical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation